University of Bristol

Dr. Sabine Hauert

Assistant Professor

Sabine Hauert is Assistant Professor in Robotics at the University of Bristol in the UK. Her research focusses in designing swarms that work in large numbers (>1000), and at small scales (<1 cm). Profoundly cross-disciplinary, Sabine works between Engineering Mathematics, the Bristol Robotics Laboratory, and Life Sciences. Before joining the University of Bristol, Sabine engineered swarms of nanoparticles for cancer treatment at MIT, and deployed swarms of flying robots at EPFL.

Sabine is also President and Co-founder of, a non-profit dedicated to connecting the robotics community to the world. As an expert in science communication with 10 years of experience, Sabine is often invited to discuss the future of robotics and AI, including in the journals Science and Nature, at the European Parliament, and at the Royal Society. Her work has been featured in mainstream media including BBC, CNN, The Guardian, The Economist, TEDx, WIRED, and New Scientist.



Dr. Namid Shatil

Postdoctoral Researcher

Namid Shatil is a post-doctoral researcher in the department of Engineering Mathematics at the University of Bristol. He received his BSc in Mathematics & Philosophy from the University of York before beginning his PhD in Applied Nano-technology at the University of Bristol in 2018. His main interests include nano-scale and multi-scale systems, numerical simulations, data analysis, and computational biology. 


Dr. Scott McCormick

Postdoctoral Researcher

Scott McCormick received his B.Sc (Hons) in Nanotechnology from Flinders University in Australia, and graduated with his PhD from the University of South Australia. His interests include microfluidics, bioprinting and regenerative medicine.

Scott is also acting as the science-communications coordinator for EVO-NANO, and will be bringing information across from all the contributors on progress into this amazing project. He is also working on the microfluidic application of visualizing nanoparticle penetration into an in vitro tissue analogue using microfluidics.